What is Channel Medsystems?
Channel Medsystems operates at the intersection of medical device innovation and women's health. The company focuses on the research, development, and commercialization of treatments that meet the rigorous standards of modern clinical practice. By prioritizing patient-centric design, Channel Medsystems aims to improve outcomes while simultaneously addressing the economic efficiencies required by healthcare systems. Its position in the market is bolstered by a robust intellectual property portfolio and a clear focus on high-impact, minimally invasive technologies that redefine the standard of care for women globally.
How much funding has Channel Medsystems raised?
Channel Medsystems has raised a total of $54.8M across 5 funding rounds:
Series A
$1M
Series B
$9.8M
Debt
$6M
Private Equity
$23.9M
Series C
$14.1M
Series A (2012): $1M, investors not publicly disclosed
Series B (2013): $9.8M, investors not publicly disclosed
Debt (2014): $6M, investors not publicly disclosed
Private Equity (2015): $23.9M, investors not publicly disclosed
Series C (2017): $14.1M backed by Scientific Health Development, Aperture Venture Partners, LLC, InCube Ventures, Boston Scientific, Third Point Ventures, and Longwood Fund
Key Investors in Channel Medsystems
Scientific Health Development
Scientific Health Development is a Dallas-based venture capital firm that specializes in early-stage medtech investments, targeting companies that address unmet clinical needs with easily adoptable technologies.
Aperture Venture Partners, LLC
APERTURE Venture Partners is a healthcare-focused investment firm dedicated to collaborating with exceptional entrepreneurs to develop innovative companies in the medical device and diagnostic sectors.
InCube Ventures
InCube Ventures is a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations, led by prolific inventor and entrepreneur Mir Imran.
What's next for Channel Medsystems?
Looking ahead, Channel Medsystems is well-positioned to leverage its recent capital injection to accelerate the commercialization of its pipeline and expand its market footprint. The company's strategic roadmap likely involves scaling its manufacturing capabilities and deepening its clinical research initiatives to support broader adoption of its technologies. Given the involvement of high-profile venture capital firms and strategic industry players, the firm is poised to maintain its competitive edge in the medtech landscape, potentially exploring further market penetration or strategic partnerships that align with its long-term vision of transforming women's healthcare delivery.
See full Channel Medsystems company page
